Intuitive Surgical reported revenue of $2.87 billion for the quarter, an 18.8% year-over-year increase, driven by continued da Vinci system placements and consumable sales. The company delivered adjusted EPS of $2.53, topping consensus estimates by $0.26. Net margin improved to 28.4%, and return on equity held at 15.1%. Management reiterated its long-term target of mid-teens operating margins but issued guidance below street expectations for the upcoming quarter, citing anticipated deceleration in system sales and temporary product supply constraints.

In the third quarter, Alpha Cubed Investments LLC increased its ISRG stake by 13.0%, acquiring 10,677 additional shares to reach 92,600 shares, representing 1.4% of its total portfolio. Valley Wealth Managers raised its position by 52.7% to 4,084 shares, while Strategic Advisors LLC expanded by 63.3% to 10,397 shares. Overall, institutional investors now hold 83.6% of Intuitive Surgical’s equity, underscoring broad confidence among large asset managers despite near-term guidance concerns.

The FDA granted new clearance expanding the da Vinci 5 system into select advanced cardiac procedures, opening a multi-billion-dollar addressable market for both systems and disposable instruments. This expansion adds a long-term revenue tail as hospitals invest in robotic platforms for minimally invasive, high-precision cardiovascular surgery. Clinical studies presented at recent medical conferences demonstrated a 25% reduction in operative times and a 15% decrease in post-operative complications for robotic-assisted cardiac cases.

Sell-side support remains strong, with TD Cowen initiating coverage at Strong Buy and Barclays reaffirming its Buy rating. HSBC raised its price target following the earnings beat, while Evercore ISI trimmed its target amid valuation concerns. Of 25 analysts covering the stock, 16 carry Buy or Strong Buy ratings and eight rate it Hold. The consensus reflects moderate buy sentiment, highlighting diverging views on the valuation multiple but a shared expectation of robust cash flow generation over the next three fiscal years.